BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bayram S, Akkız H, Bekar A, Akgöllü E, Yıldırım S. The significance of Exonuclease 1 K589E polymorphism on hepatocellular carcinoma susceptibility in the Turkish population: a case-control study. Mol Biol Rep 2012;39:5943-51. [PMID: 22205538 DOI: 10.1007/s11033-011-1406-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Wang Y, Zhang S, Wang L. Exonuclease-Catalyzed Methylene Blue Releasing and Enriching onto a Dodecanethiol Monolayer for an Immobilization-Free and Highly Sensitive Electrochemical Nucleic Acid Biosensor. Langmuir 2017;33:5099-107. [DOI: 10.1021/acs.langmuir.6b04671] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ghaderi-Zefrehi H, Rezaei M, Sadeghi F, Heiat M. Genetic polymorphisms in DNA repair genes and hepatocellular carcinoma risk. DNA Repair (Amst) 2021;107:103196. [PMID: 34416543 DOI: 10.1016/j.dnarep.2021.103196] [Reference Citation Analysis]
3 Gillman R, Lopes Floro K, Wankell M, Hebbard L. The role of DNA damage and repair in liver cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188493. [PMID: 33316376 DOI: 10.1016/j.bbcan.2020.188493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Yang SF, Chang CW, Wei RJ, Shiue YL, Wang SN, Yeh YT. Involvement of DNA damage response pathways in hepatocellular carcinoma. Biomed Res Int 2014;2014:153867. [PMID: 24877058 DOI: 10.1155/2014/153867] [Cited by in Crossref: 21] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
5 Tan S, Qin R, Zhu X, Tan C, Song J, Qin L, Liu L, Huang X, Li A, Qiu X. Associations between single-nucleotide polymorphisms of human exonuclease 1 and the risk of hepatocellular carcinoma. Oncotarget 2016;7:87180-93. [PMID: 27894089 DOI: 10.18632/oncotarget.13517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
6 Yang G, Dong K, Zhang Z, Zhang E, Liang B, Chen X, Huang Z. EXO1 Plays a Carcinogenic Role in Hepatocellular Carcinoma and is related to the regulation of FOXP3. J Cancer 2020;11:4917-32. [PMID: 32626539 DOI: 10.7150/jca.40673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Imtiaz H, Afroz S, Hossain MA, Bellah SF, Rahman MM, Kadir MS, Sultana R, Mazid MA, Rahman MM. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population. Tumour Biol 2019;41:1010428319830837. [PMID: 30880589 DOI: 10.1177/1010428319830837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang M, Zhao D, Yan C, Zhang L, Liang C. Associations between Nine Polymorphisms in EXO1 and Cancer Susceptibility: A Systematic Review and Meta-Analysis of 39 Case-control Studies. Sci Rep 2016;6:29270. [PMID: 27387683 DOI: 10.1038/srep29270] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
9 Bayram S, Akkız H, Ülger Y, Bekar A, Akgöllü E, Yıldırım S. Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: a case-control study. Gene 2012;511:308-13. [PMID: 23041554 DOI: 10.1016/j.gene.2012.09.119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
10 Zhang Q, Kong D. A general fluorescent sensor design strategy for “turn-on” activity detection of exonucleases and restriction endonucleases based on graphene oxide. Analyst 2013;138:6437. [DOI: 10.1039/c3an01447a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
11 Wang S, Cai W, Li J, An W, Zheng H, Liao M. Bioinformatics Analysis and Experimental Study of Exonuclease 1 Gene in Lung Adenocarcinoma. Biochem Genet 2022. [PMID: 35169964 DOI: 10.1007/s10528-022-10190-y] [Reference Citation Analysis]
12 Deng X, Liang J, Jiang M, Zhou X, Liu H. Association between the C.1161G>A and C.1779C>G genetic variants of XRCC1 gene and hepatocellular carcinoma risk in Chinese population. Int J Biol Sci 2013;9:289-94. [PMID: 23493666 DOI: 10.7150/ijbs.5928] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Fu Q, Yang F, Zhao J, Yang X, Xiang T, Huai G, Zhang J, Wei L, Deng S, Yang H. Bioinformatical identification of key pathways and genes in human hepatocellular carcinoma after CSN5 depletion. Cell Signal 2018;49:79-86. [PMID: 29885455 DOI: 10.1016/j.cellsig.2018.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Yan S, Gao S, Zhou P. Multi-functions of exonuclease 1 in DNA damage response and cancer susceptibility. Radiation Medicine and Protection 2021;2:146-54. [DOI: 10.1016/j.radmp.2021.08.004] [Reference Citation Analysis]
15 Pan Q, Long X, Song L, Zhao D, Li X, Li D, Li M, Zhou J, Tang X, Ren H, Ding K. Transcriptome sequencing identified hub genes for hepatocellular carcinoma by weighted-gene co-expression analysis. Oncotarget 2016;7:38487-99. [PMID: 27220887 DOI: 10.18632/oncotarget.9555] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
16 Duan F, Song C, Dai L, Cui S, Zhang X, Zhao X. The significance of Exo1 K589E polymorphism on cancer susceptibility: evidence based on a meta-analysis. PLoS One 2014;9:e96764. [PMID: 24810280 DOI: 10.1371/journal.pone.0096764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
17 Dai Y, Tang Z, Yang Z, Zhang L, Deng Q, Zhang X, Yu Y, Liu X, Zhu J. EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients. Cell Cycle 2018;17:2386-97. [PMID: 30328366 DOI: 10.1080/15384101.2018.1534511] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
18 Chen J, Ma L, Peng NF, Wang SJ, Li LQ. A meta-analysis of the relationship between glutathione S-transferases gene polymorphism and hepatocellular carcinoma in Asian population. Mol Biol Rep. 2012;39:10383-10393. [PMID: 23053942 DOI: 10.1007/s11033-012-1917-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
19 Keijzers G, Bakula D, Petr MA, Madsen NGK, Teklu A, Mkrtchyan G, Osborne B, Scheibye-Knudsen M. Human Exonuclease 1 (EXO1) Regulatory Functions in DNA Replication with Putative Roles in Cancer. Int J Mol Sci 2018;20:E74. [PMID: 30585186 DOI: 10.3390/ijms20010074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
20 Chen ZY, Zheng SR, Zhong JH, Zhuang XD, Zhou JY. Association between three exonuclease 1 polymorphisms and cancer risks: a meta-analysis. Onco Targets Ther 2016;9:899-910. [PMID: 26966378 DOI: 10.2147/OTT.S95258] [Cited by in F6Publishing: 3] [Reference Citation Analysis]